Trial intelligence / Profile preview

Liuhedan plaster for postoperative recovery after head and neck cancer surgery

ChiCTR2500095542Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jan 2025
Countries
1
01

Overview

Phase 4, open-label trial of Liuhedan Plaster in head and neck cancer (HNC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Pain score and Wound redness and swelling score. Started Jan 2025; status: recruiting.

02

Drugs

Liuhedan Plaster
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on ChiCTR2500095542.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095542.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call